Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period.

Peter Y M Woo, Stephen Yau,Tai-Chung Lam,Jenny K S Pu,Lai-Fung Li,Louisa C Y Lui,Danny T M Chan,Herbert H F Loong,Michael W Y Lee,Rebecca Yeung,Carol C H Kwok, Siu-Kie Au, Tze-Ching Tan,Amanda N C Kan, Tony K T Chan,Calvin H K Mak,Henry K F Mak,Jason M K Ho,Ka-Man Cheung,Teresa P K Tse, Sarah S N Lau, Joyce S W Chow,Aya El-Helali,Ho-Keung Ng,Wai-Sang Poon

Neuro-oncology practice（2023）

引用 4|浏览16

暂无评分

摘要

The incidence of glioblastoma in the Chinese general population is low. We charted the development of neuro-oncological care of glioblastoma patients in Hong Kong during the temozolomide era. Although there was an increased adoption of temozolomide chemoradiotherapy, a corresponding improvement in survival was not observed.

查看译文

关键词

Chinese,age standardized incidence rate,glioblastoma,overall survival,temozolomide chemoradiotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要